Clin2
NCT06749041Likely a fitNot yet recruiting

Blood Level Timing for Clozapine in Schizophrenia

Cardiovascular Side Effects of ClozapineNeutropenia Due to ClozapineGeneral Side Effects of ClozapineConstipation Due to ClozapineSymptoms of SchizophreniaOptimal Blood Sampling Time for Clozapine in Patients Who Receive Clozapine Once and Twice DailyClozapine and Norclozapine Plasma Level Concentrations

Part of Blood & lymphatic clinical trials.

This study looks at how clozapine and its byproduct (norclozapine) move through your body, and aims to find the best time to test your blood levels. It may help your doctor adjust your dose to reduce side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You are between 18 and 70 years old.
  • You have been on a stable daily dose of clozapine for at least one week.
  • You are not pregnant and do not have cancer or take immune-suppressing drugs.
  • You have routine blood tests for white blood cells every 3 months or more often.
  • You have had at least two blood draws after the last dose of clozapine (elimination phase).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05316883Recruiting· Phase 4
Testing blood markers in people on clozapine for schizophrenia

This study looks at “biomarkers,” or blood measures, in people with schizophrenia who respond to clozapine. It may help researchers understand who benefits from clozapine and why, by linking test results to symptom changes.

Glostrup Municipality, Denmark
NCT06634641Recruiting· Phase 4
Clozapine and immune function in Parkinson's disease

This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.

Salouël
NCT02639702Recruiting· Phase 4
Switching from twice-daily to once-daily clozapine for schizophrenia

This trial tests whether taking clozapine once a day (instead of twice a day) works safely for people with schizophrenia. It may help by simplifying your dosing schedule while closely monitoring your wellbeing.

Toronto, Ontario
NCT06011460Enrolling by invitation
Observing clozapine safety for bipolar depression

This study is testing whether clozapine, a medication usually used for schizophrenia, is safe for treating hard-to-treat depression in people with bipolar disorder. It may help if you have not found relief from other treatments.

Gdansk, Pomeranian Voivodeship
NCT04580134Recruiting· Phase 4
Clozapine study for people with a specific schizophrenia or bipolar type

This trial tests whether clozapine works better for people whose illness fits a specific “biotype-1” pattern. It may help reduce ongoing symptoms, but it also requires close safety monitoring.

Hartford, Connecticut
NCT05208190Recruiting· Phase 4
Clozapine to prevent violence in schizophrenia

This trial tests whether clozapine can reduce repeat violent behavior in people with schizophrenia or schizoaffective disorder. Participants are randomly assigned to clozapine or usual care to see which approach works better for preventing violence.

Los Angeles, California

Hear when a new Cardiovascular Side Effects of Clozapine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.